Virginia Retirement Systems Et Al Kodiak Sciences Inc. Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$7.09 - $89.45 $26,942 - $339,910	-3,800 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$81.97 - $106.94 $24,591 - $32,082	300 Added 8.57%	3,800 $365,000
Q2 2021 Aug 13, 2021	SELL	$77.2 - $126.54 $23,160 - $37,962	-300 Reduced 7.89%	3,500 $326,000
Q1 2021 Apr 30, 2021	SELL	$110.45 - $164.47 $198,810 - $296,046	-1,800 Reduced 32.14%	3,800 $431,000
Q4 2020 Feb 16, 2021	SELL	$60.78 - $154.03 $249,198 - $631,523	-4,100 Reduced 42.27%	5,600 $823,000
Q3 2020 Nov 12, 2020	BUY	$45.05 - $59.27 $436,985 - $574,919	9,700 New	9,700 $574,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.